TY  - CONF

T1  - Dupilumab treatment improves health-related quality of life in children aged 6 months-5 years with moderate-to-severe atopic dermatitis

JO  - BRITISH JOURNAL OF DERMATOLOGY

PY  - 2022/01/01

AU  - Paller AS

AU  - Simpson EL

AU  - Siegfried EC

AU  - Cork MJ

AU  - Wollenberg A

AU  - Arkwright PD

AU  - Zhang H

AU  - Wang Z

AU  - Rodriguez Marco A

ED  - 

VL  - 187

IS  - 3

SP  - E104

EP  - E105

Y2  - 2024/12/22

ER  -